Last reviewed · How we verify
Ocular histoplasmosis syndrome
Approved treatments
- Visudyne · Bausch Lomb Ireland
Visudyne selectively binds to neovascular tissue, which is then activated by light to induce a phototoxic reaction. - Visudyne · Bayer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Ocular histoplasmosis syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Ocular histoplasmosis syndrome treatment landscape brief
- Ocular histoplasmosis syndrome treatment updates RSS
Frequently asked questions about Ocular histoplasmosis syndrome
What drugs treat Ocular histoplasmosis syndrome?
Tracked treatments include Visudyne.
What is the treatment for Ocular histoplasmosis syndrome?
Standard treatment for Ocular histoplasmosis syndrome includes Visudyne. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Ocular histoplasmosis syndrome patent cliff · Ocular histoplasmosis syndrome CI report
- Treatment: Visudyne · Bausch Lomb Ireland
- Treatment: Visudyne · Bayer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing